Turkey has administered more than 65 million doses of COVID-19 vaccines since it launched a mass vaccination campaign in January, according to figures released on July 23.
The country is continuing its intensive vaccination campaign to curb the virus's spread, with all people aged 18 and over currently eligible for vaccine shots.
"Today, at 10 am, a session of the National Immunization Body will be held, which will give an opinion to the Crisis Staff on the third dose, and next week, the Crisis Staff will sit down and give recommendations," Brnabi told TV Pink.
Brnabic emphasized that a way must be found to additionally motivate people to get vaccinated.
As many as 8,063 doses of Pfizer, Moderna, AstraZeneca and Johnson & Johnson vaccines have been administered in the last 24 hours, of which 4,591 representing the first dose and 3,472 the second dose, according to a report sent on Sunday by the National Coordinating Committee for Vaccination Activities against COVID-19 (CNCAV).
Concerns are also rising about the effectiveness of vaccines against the Beta variant
Turkey has started to administer its homegrown COVID-19 vaccine candidate to volunteers at a major hospital in the capital Ankara as part of the jab's Phase 3 clinical trials to compare its efficacy to that of the Chinese-developed CoronaVac shot, the country's top health official announced on July 16.
According to him, there are enough vaccines, and citizens can choose. Loncar said that such a request would not make sense if the state did not provide enough vaccines for all citizens, and pointed out that citizens do not think about the costs of treatment because they know that the state pays for it.
One person died.
There are currently four patients on respirators.
The current epidemiological situation in Serbia is still stable, experts claim, but they warn that excessive relaxation can cost us. Dr Mirsad Djerlek said that the delta strain of coronavirus is registered in our country and that it will only show its strength.
In the past 24 hours, 14,608 doses of Pfizer, Moderna, AstraZeneca and Johnson&Johnson vaccines were administered, of which 9,007 represented the first dose and 5,601 the second dose, according to a report sent on Tuesday by the National Committee Coordinating COVID-19 Vaccination Activities (CNCAV).